SEC filings and other documents

Net income and FFO rose year-over-year, with growth supported by property income and lower interest expense.

Trustee elections, executive pay, and auditor ratification all passed with no shareholder questions.

Net income and FFO rose year-over-year, with expanded credit and new development underway.

Net income and FFO dipped, with new development underway and higher borrowing costs noted.

Q3 2025 net income was steady, but FFO rose and new development supports future growth.

Raised 2025 guidance after strong Q2 results and incremental Medicaid reimbursements.

Trustees, executive pay, and auditor were approved by shareholders in a virtual meeting.

Strong revenue and earnings growth offset by cash flow pressures and ongoing regulatory risks.

Net income and FFO rose year-over-year, supported by property income and prudent capital actions.

Net income and FFO rose year-over-year, with expanded credit capacity and ongoing industry risks.

Q2 net income and FFO increased year-over-year, with higher dividends and ongoing industry risks.

All proposals, including trustee elections and auditor ratification, were approved by shareholders.